Repurposing drugs to target nonalcoholic steatohepatitis.

Volume: 25, Issue: 15, Pages: 1783 - 1796
Published: Apr 21, 2019
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a complex disorder that has evolved in recent years as the leading global cause of chronic liver damage. The main obstacle to better disease management pertains to the lack of approved pharmacological interventions for the treatment of nonalcoholic steatohepatitis (NASH) and NASH-fibrosis-the severe histological forms. Over the past decade, tremendous advances have been made in NAFLD research,...
Paper Details
Title
Repurposing drugs to target nonalcoholic steatohepatitis.
Published Date
Apr 21, 2019
Volume
25
Issue
15
Pages
1783 - 1796
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.